Graves' Orbitopathy is a relatively rare and difficult disease to manage. Many of the treatments have not been subjected to rigorous scientific evaluation. A major obstacle to improving the management of this condition is that no individual centre has access to sufficiently large numbers of patients for adequately powered randomised controlled clinical trials.
EUGOGO was established by European centres which have long experience in managing patients with Graves’ Orbitopathy within a multidisciplinary framework, have a track record in clinical research in this condition, and constitute large regional or national referral centres.
EUGOGO is a consortium of clinicians (endocrinologists and ophthalmologists), clinical epidemiologists and radiologists, committed to improving the management of patients with Graves' Orbitopathy within a multidisciplinary and scientific context.
EUGOGO aims to
- contribute towards understanding the pathogenesis of Graves’ Orbitopathy and improving the management of patients, through collaborative scientific basic and clinical research,
- contribute towards education, teaching and training of health professionals involved in the care of patients with Graves’ Orbitopathy and
- raise funds to support its activities.